Effect of Different Maternal Hemoglobin and Hematocrit Values on Perinatal Outcome

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06726915

Enrollment

403

Registered

2024-12-10

Start date

2025-01-31

Completion date

2026-05-31

Last updated

2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemoglobin and Hematocrit Values on Perinatal Outcome

Brief summary

This study aims to evaluate the perinatal outcome in pregnancies with different levels of hemoglobin/hematocrit to verify which category of women should have iron supplementation if not all.

Detailed description

Anaemia in pregnant women has been reported to have various adverse effects on both the mother and unborn foetus. These effects include preterm birth, a low birth weight and an increase in the risk of maternal and perinatal mortality . Postpartum anaemia impairs wound healing, increases the risk for readmission and/or prolonged hospitalization, and increases the cost of care for families . Some investigators stated adverse perinatal outcome in pregnant mothers with high haemoglobin and haematocrit values and raised a question about the possible harmful effect of iron supplementation in such pregnancies.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Inclusion criteria

* 1\. Pregnant women scheduled for labor or C.S (at term, 28-42 weeks). 3. Singleton pregnancy. 4. Age range: 18-40 years. 5. Willing to provide informed consent for participation and follow-up.

Exclusion criteria

1. Refusal to participate or consent. 2. Presence of non-iron deficiency anemia (e.g., hemoglobinopathies, chronic disease-related anemia). 3. Multiple pregnancies (e.g., twins or more). 4. Antepartum hemorrhage (e.g., placenta previa, placental abruption). 5. PAS. 6. Malformed fetus. -

Design outcomes

Primary

Measure	Time frame
Fetal weight measurement- still birth or major morbidity	Baseline

Secondary

Measure	Time frame
Maternal needs for iron therapy	Baseline
. Un-even postpartum period: Failure of lactation- DVT- CS wound complications Postpartum anaemia	Baseline

Contacts

Primary ContactAli Mohamed Ammar, Graduate

aliammar2237@gmail.com0201032760152

Backup ContactHassan Salah Kamel

hkamelhkamel@yahoo.com+20 1006664910

Outcome results